Emerging Infectious Diseases

BARDA, BioFire Defense partner on new molecular panel to test human coronaviruses

A new partnership united BioFire Defense, LLC, and the U.S. Biomedical Advanced Research and Development Authority (BARDA) last week under…

2 years ago

NIAID partners with Democratic Republic of the Congo for new trial of monkeypox antiviral TPOXX

Together, the Democratic Republic of the Congo (DRC) National Institute for Biomedical Research (INRB) and the United States National Institute…

2 years ago

BARDA, DIazyme Laboratories developing rapid test to measure neutralizing SARS-CoV-2 antibodies

Through a new partnership with Diazyme Laboratories, Inc., the Biomedical Advanced Research and Development Authority (BARDA) announced this week that…

2 years ago

HHS revises PREP Act declaration to increase number of people able to administer monkeypox vaccines

In order to expand the number of providers able to administer vaccines against monkeypox, smallpox, and other orthopoxviruses, the U.S.…

2 years ago

Bipartisan dozen in Congress urge FDA to pursue broad array of therapeutics for COVID-19 variants

In a letter to U.S. Food and Drug Administration (FDA) Commissioner Robert Califf, M.D. last month, 12 members of Congress…

2 years ago

Simplexa COVID-19 Direct becomes second COVID diagnostic test cleared by FDA

After being backed by the Biomedical Advanced Research and Development Authority (BARDA) under public-private partnerships, the office recently announced that…

2 years ago

NIAID begins Phase 3 clinical trial to evaluate TPOXX monkeypox antiviral

The AIDS Clinical Trials Group began enrolling more than 500 adults and children for a Phase 3 clinical trial of…

2 years ago

Financial intermediary fund for pandemic prevention, preparedness and response launches with WHO, World Bank support

Looking to get ahead of future health concerns, a new financial intermediary fund (FIF) was officially launched last week by…

2 years ago

AmerisourceBergen wins nearly $20M HHS contract to improve deliveries of monkeypox vaccines, treatments

The U.S. Department of Health and Human Services recently awarded AmerisourceBergen a $19.8 million contract to improve the delivery of…

2 years ago

BARDA, Arcturus Therapeutics Holdings jointly developing self-amplifying mRNA-based flu vaccine

The Biomedical Advanced Research and Development Authority (BARDA) announced a new partnership with Arcturus Therapeutics Holdings, Inc. this week, which…

2 years ago

This website uses cookies.